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Prevention of Pediatric Mortality Associated with Malaria: An Exhaustive Literature 
Review 
 Elimination and eradication of malaria, a deadly yet preventable disease most often 
caused by the bite of female Anopheles mosquitos that harbor Plasmodium parasites, have been 
goals of the World Health Organization (WHO) since 1955 (Centers for Disease Control and 
Prevention [CDC], 2017). While complete eradication is unlikely in the coming years, significant 
progress has been made to reduce morbidity and mortality associated with malaria, including 99 
countries that have since been designated as malaria-free. Between 2000 and 2015, the WHO 
showed a global reduction in the rates of incidence and mortality by 37% and 60% respectively. 
Africa, the country with the largest disease burden, experienced 943 million less cases in the 
same timeframe, and it is estimated that 70% of this can be attributed to the implementation of 
prevention and treatment interventions (Korenromp et al., 2017, p. 30; WHO, 2019).  
In spite of the these interventions and the resulting progress that was made within 15 
years, malaria remains a significant public health threat as it “is still one of the most infectious 
diseases that cause far more deaths than all patristic diseases together,” and these deaths are 
disproportionately seen among pediatric African patients (Talapko et al., 2019, p. 8). In 2017, 
there were 219 million cases recorded worldwide, an increase by 2 million from 2016, and more 
than 90% of these occurred in Sub-Saharan Africa. Of the 219 million total cases, there were 
approximately 435,000 resulting deaths with more than 60% of these being children below the 
age of 5-years old. This translates to a child under the age of 5 dying every two minutes from a 
disease that is both preventable and treatable (United Nations Children’s Fund [UNICEF], 2019). 
Many studies fail to address this plateau and regression in the fight against malaria, specifically 
in countries such as Nigeria and the Democratic Republic of Congo that have seen a marked 
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increase in cases over the last 5 years. The purpose of this literature review is to assess what 
factors have contributed to this stagnation, and what interventions can best mitigate the effects of 
malaria in vulnerable pediatric African populations. 
Methods 
Information Source and Search Strategy 
 A Boolean search was conducted in August 2020 using the CINAHL Complete database. 
The single search consisted of multiple phrases including: (a) pediatric OR child OR children OR 
infant; (b) malaria; (c) prevention OR intervention OR treatment OR program; and (d) Africa OR 
African countries. This search yielded 565 results, but many were focused on anemia or sickle 
cell anemia due to its high prevalence in Africa, so an additional Boolean phrase (e) NOT sickle 
cell anemia OR anemia OR anaemia was added which resulted in a total of 463 articles. 
Eligibility Criteria 
To narrow down the search further, it was limited by inclusion criteria of research articles 
that were peer reviewed, had the full text and abstract available, written in the English language, 
and published in academic journals between 2015-2020. This resulted in a total of 94 articles, 60 
of which were excluded based on their title focusing on information or populations irrelevant to 
this review such as reproductive health, nutrition programs, community health workers, reporting 
systems, pneumonia, and HIV or AIDS. Of these 34 articles, an additional 8 were excluded after 
evaluating their abstract. A full text assessment excluded 6 more articles that had a small sample 
size, lacked an outcome of interest, or focused on a population other than pediatric patients. This 
resulted in a final outcome of 20 articles being selected for the literature review as illustrated in 
Figure 1.  
FIGURE 1  
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Inclusion and Exclusion Criteria Diagram  
Articles identified by initial 
search strategy: 
(n=463) 
Articles included after applying 
limiters: 
(n=94) 
Articles considered relevant 
based on title: 
(n=34) 
Articles selected for a full text 
assessment: 
(n=26) 
Articles included in literature 
review: 
(n=20) 
Articles excluded after assessing 
abstract:  
(n=8) 
Articles excluded based on 
full text assessment:  
(n=6) 
 
a. Small sample size 
        (n=1) 
b. No outcome of interest 
        (n=3) 
c. Population focus not 
pediatric patients 
        (n=2) 
 
 




 Of the 20 articles selected by the search strategy, common themes regarding both 
protective and risk factors associated with pediatric mortality secondary to malaria were 
identified including prevention interventions, socioeconomic factors, improved diagnostics and 
treatment, and the necessity of adequate funding. Four primary studies—Akoakwah et al. (2018), 
Jakubowski et al. (2017), Bikundi & Coppieteres (2017), and Ndong et al. (2019)—highlighted 
these and were evaluated at greater depth. The characteristics of these studies are summarized in 
Table 1. 
Prevention Interventions 
The multifaceted interventions that have been implemented to combat malaria are 
primarily focused on vector control to reduce exposure to the Plasmodium parasite and prevent 
infection in the first place. One of the cheapest and most common methods is the use of a bed net 
as a physical barrier while sleeping, especially for vulnerable populations such as children and 
pregnant women. Insecticide-treated bed nets (ITNs) offer additional protection serving as a 
physical barrier along with insecticidal effects; however, retreatment is necessary over time as 
the insecticide wears off. Even if most households have received ITNs, studies have shown the 
added barriers of increased cost and lack of understanding regarding retreatment can negatively 
impact proper adherence, thereby decreasing the effectiveness of the ITN. This has been partially 
mitigated through the development of long-lasting insecticide-treated nets (LLINs) that have the 
insecticide interwoven in its fibers. Retreatment is not necessary, and they remain effective for 3-
5 years (CDC, 2019). 
 Insecticidal vector control in high burden regions has also depended on the use of indoor 
residual spraying (IRS) which involves long-lasting insecticides being sprayed on the internal 
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walls and ceilings of buildings. IRS is known to be effective as most vectors that carry malaria 
are endophilic meaning when they enter a dwelling in search of a source of nourishment, they 
consume blood and proceed to rest on walls or other surfaces nearby for a period of time. If this 
surface has been treated with IRS, a fatal dose of insecticides will be absorbed by the vector. 
This particularly helps minimize malaria transmission within a neighborhood or community if a 
majority of the buildings and houses have been treated, with a minimum treatment goal of 80% 
and ideal treatment goal of 100% (WHO, 2015, pp. 4-5 & 41).   
 Many studies have suggested that IRS may offer more protection than ITNs or LLINs as 
seen with Afoakwah et al (2018). This cross-sectional study assessed malaria infection and 
accompanying prevention interventions in 2,449 children under the age of 5-years old in Ghana, 
Africa using the Ghana Demographic and Health Surveys of 2014. Of the children included in 
the study, approximately 40% had tested positive for malaria when a rapid diagnostic test (RDT) 
was performed. The prevalence of malaria among the study participants that were protected with 
IRS was only 36%, while the prevalence of malaria among the participants that solely relied on 
an ITN was increased at 45% (pp 4-6). This finding was supported by Katureebe et al. (2016) as 
their study showed LLINs had a slight but varying effect on the human biting rate of vectors, 
malaria test positivity rate, and incidence of malaria in Uganda while IRS resulted in a 
significant decline of all three indicators (p. 2). Selvaraj et al. (2018) also found that IRS can 
greatly reduce the prevalence of malaria as spraying insecticides at the end of August during the 
peak of the wet season can result in as much as an 80% reduction of cases the following year (p. 
8).   
Socioeconomic Factors 
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 In addition to the benefits of IRS, Afoakwah et al (2018) found evidence that maternal 
education status can impact the incidence of malaria in children. The prevalence in children 
under the age of 5-years old was 26% if the mother had a secondary education or higher but was 
54% in children whose mothers lacked any formal education (p. 6). Socioeconomic factors 
associated with malaria infection were also assessed in a cross-sectional study by Bikundi & 
Copppieters (2017). This study involved 61,292 children under the age of 5-years old in 16 sub-
Saharan African countries using data collected from the Demographic and Health Surveys and 
Malaria Indicator Surveys between 2010 and 2015. Of the 29.1% of subjects that had malaria as 
identified using RDTs, there was a significant association with the maternal education level. 
More than 91% of these children had a mother that was illiterate or only had a primary level of 
education. Wealth status was also shown to impact the risk a child faces as 29% of those that 
tested positive belonged to the poorest households, while only 6% belonged to the richest (pp. 
398-399).  
 Numerous other studies have had similar results. Bisi-Onyemaechi et al. (2017) 
conducted a study in Nigeria and while 85% of the subjects owned an ITN, only 53% of them 
reported using it. Educational status was the most significant factor as those with a secondary or 
tertiary level of education accounted for 89% of those that used their ITN (p. 1038). In rural 
areas of Ethiopia, Muchie et al. (2017) found that a household was 60% more likely to own a net 
if they had a secondary education or higher (pp. 3-5). Fokam et al. (2017) found that 63% of the 
384 households assessed in Cameroon owned a bed net while only 69% of them used it (p. 8). As 
with the previous studies, those with a lower educational level had lower odds of utilizing the 
net. Tusting et al. (2017) assessed 284,532 children from 21 countries in sub-Saharan Africa and 
determined wealth and housing can impact the risk of malaria infection. Regardless of ITN 
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ownership or IRS use, living in modern housing had a 9-14% reduction in the odds of infection 
(p. 6). Similarly, another study found that factors not commonly associated with modern housing 
contributed to higher rates of infection. Those diagnosed with malaria had 75% lower odds of 
having waste collection devices in the home and were 4 times more likely to have slept outdoors 
(Tesfahunegn et al., 2017, pp. 3-4).   
Improved Diagnostics and Treatment 
 Because prevention interventions are not infallible and proper adherence can be impacted 
by numerous factors, another method to prevent pediatric mortality associated with malaria is to 
improve early diagnostics and treatment of the disease. The campaigns associated with this are 
primarily referred to as mass testing, treatment, and tracking (MTTT) and mass drug 
administration (MDA) (Hayes et al., 2017, p. 2). Ndong et al. (2019) completed a longitudinal 
study in Ghana involving 5000 subjects, 597 of which were under the age of 5-years old. The 
study utilized MTTT to diagnose and treat asymptomatic carriers of malaria as they can help 
perpetuate outbreaks within a community. The researchers performed RDTs every 4 months 
between 2017 and 2018 with coverage ranging between 78-99%. 96 participants were 
determined to have symptomatic malaria infection, but MTTT increased access to artemisinin-
based combination therapy (ACT) and decreased symptomatic cases by 4.2% during the year it 
was implemented (pp. 4-6). Asymptomatic parasitemia was decreased by 24% (p. 1). 
 Other forms of treatment have centered on intermittent preventive treatment (IPT) with 
sulfadoxine-pyrimethamine during pregnancy to help prevent infant mortality associated with 
maternal malaria infections due to the increased vulnerability in these populations. Adeoye & 
Fagbamigbe (2019) found that women that received at least two doses of the medication during 
pregnancy had 28% lower odds of infant mortality (p. 142). While more recently implemented, 
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the WHO has also contributed to the development of a vaccine that had been tested in clinical 
trials through 2014 with a goal of administering the pilot dose to children in Ghana, Kenya, and 
Malawi in 2018 (2017).  
Necessity of Adequate Funding 
 While the aforementioned prevention techniques and treatment options may be effective, 
they all require sufficient funding for implementation. Bjorkman et al. (2019) showed that all-
cause mortality among children under the age of 5-years old decreased by 72% after 
implementing ACT and vector control programs in the 2000s, and this coincides with the 
introduction of substantial international funding programs (p. 2). Jakubowski et al. (2017) 
assessed the impact the United States President’s Malaria Initiative (PMI) had on 2,112,951 
children in 32 sub-Saharan African countries in a longitudinal study from 1995 to 2014. PMI has 
been a leading source of funding in the fight against malaria since 2005, and this study found 
there was an association between the implementation of PMI and a 16% reduction in the risk of 
child mortality in countries included in the initiative. Moreover, “each additional dollar disbursed 
through PMI was associated with a reduction in the annual risk of under-5 mortality” (p. 8). 
There was also an 8.3% increase in ITN and 6.6% increase in IRS coverage (p. 10). 
Funding in recent years has decreased, however, and there are estimates that tens of 
thousands may die as a result. While the WHO has a current annual goal of US $5.6 billion for 
adequate funding, 2019 totals only reached $3 million (WHO, 2020). Boakye et al. (2018) 
addressed this shift in funding. Although community case management programs have helped in 
the delivery of interventions and treatment, their sustainability is decreasing due to plateauing 
funds. Providers have observed decreased access to necessary commodities such as bed nets, 
medications, and RDTs (p. 4-6).  




Data Extraction and Characteristics of Primary Studies 
Study Study Design Subjects Findings 
Afoakwah, 









Approximately 40% of the subjects 
tested positive for malaria via a RDT. 
The prevalence of malaria was 36% for 
those using IRS, and 45% for those using 
ITNs. Sole ITN use was only associated 
with a reduced incidence of malaria if the 









under 5 years of 
age in 16 
countries in sub-
Saharan Africa 
29.1% of the subjects tested positive for 
malaria. Approximately 63% of these 
subjects had mothers that were illiterate, 
and 28.5% had a mother with only a 
primary level of education. 55% 
belonged to economic levels designated 
as poor or the poorest of the study.  






children under 5 
years of age in 
Ghana, Africa 
RDTs were performed every 4 months 
for a year with each subject receiving a 
median of 3 tests. Coverage varied 
between 77.8 to 98.8% at its peak. 
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Asymptomatic parasitemia decreased by 










children in 32 
countries in sub-
Saharan Africa 
The PMI introduced significant funding 
for sub-Saharan African countries. 9.4% 
of the subjects died before the age of 5; 
however, there was a 16% reduction in 
risk of child mortality, and the coverage 




 All of the studies referenced in this literature review highlight how prevalent malaria and 
subsequent pediatric mortality remain in sub-Saharan Africa despite the implementation of 
numerous programs to combat this phenomenon. Approximately 198,000 children in the 
Jakubowski et al. (2017) study died before the age of 5. 40% of children under the age of 5 were 
found to have malaria in the study conducted by Afoakwah et al. (2018), and 29% were 
diagnosed with malaria in Bikundi & Coppitiers’ study (2017). Out of all the prevention 
techniques utilized to reduce these rates including intermittent prophylactic treatment, bed nets, 
and insecticide spraying, IRS was the most effective and had the unique ability to protect the 
majority of a community rather than just individuals. Consequently, and unlike the other 
interventions, the efficacy of IRS was not negatively impacted by socioeconomic factors such as 
wealth, modern housing, or education status (Afoakwah et al., 2018, p. 6). Still, IRS and other 
malaria control tools require significant funding to protect African communities, and sources of 
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funding have been decreasing since 2015. The funding provided in 2019 was $2.6 billion less 
than what the WHO estimated was needed to help decrease the rise in cases that has been seen in 
recent years. Sufficient data has not yet been collected, but experts expect this gap to worsen in 
2020 and coming years due to the impact of COVID-19 (WHO, 2020). 
Implications for Practice 
As funding is so limited and will likely become more scarce, officials should dedicate 
most resources to increasing coverage of IRS. In addition to studies suggesting it is more 
effective and protects a greater number of people, considerations of socioeconomic status are not 
as pertinent. Studies found that many possess ITNs and LLINs but neglect to use them. 
Therefore, these individual interventions including IPT should be designated to those that are 
especially vulnerable such as young children and pregnant women. Providers should emphasize 
education during distribution of these products to help increase understanding and adherence—
especially if the recipient lacks an education at or above the secondary level. Finally, intermittent 
MTTT and MDA should be considered as more than 50% of children in the Ndong et al. (2019) 
study tested positive for malaria while being asymptomatic. Identifying, treating, and reducing 
the number of asymptomatic carriers can decrease the disease burden in high endemic areas.  
Strengths and Limitations 
All 4 of the primary studies included in this review had large sample sizes with a total of 
2,177,289 children from 32 different sub-Saharan African countries being assessed. This helps 
ensure the data and interpretations are more precise with narrow confidence intervals leading to 
firm, significant conclusions. Moreover, all of the outcomes were supported by other studies with 
similar findings among different patient populations in Africa. One limitation of this literature 
review, however, is the varying time frames between the studies. The duration of the study 
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performed by Ndong et al. was only 12 months long. This is drastically shorter than that of 
Jakubowski et al. which assessed data over a nearly 20-year period. Obtaining more extensive, 
long-term data could alter the outcomes observed in the former study. An additional limitation 
involves the nature of literature reviews relying on published research that analyzes current, 
accurate data. The purpose of this review is to assess changes that have occurred since 2015, but 
it is possible thorough data with a broad perspective on the issue may not be available yet. 
Furthermore, only searching the CINAHL complete database could have neglected the selection 
of studies that may be accessible in other databases. 
Implications for Future Research 
 While LLINs and IRS are effective current methods to prevent and reduce the prevalence 
of malaria, Anopheles mosquitos have started becoming resistant to the insecticides used 
including pyrethroids, organochlorines, organophosphates, and carbamates which could render 
these interventions obsolete (Bird, 2017, A51). In addition to resistance among vectors, these 
interventions include recurring costs associated with replacement nets and retreatments when the 
insecticidal sprays wear off. A cost effective and longer-term solution could be found with 
additional research and implementation of the RTS,S vaccine as data and models following 
Phase III of trials have demonstrated between 65-80% efficacy in African populations (Penny et 
al., 2015, p. 13).   
Similarly, some species of the Plasmodium parasite have become immune to antimalarial 
medications such as sulfadoxine-pyrimethamine and chloroquine which can negatively impact 
the efficacy of MTTT and MDA. As seen in the study conducted by Hayes et al. (2017), 
inaccurate dosing of antimalarial medications can contribute to this drug resistance and 
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negatively impact the outcomes of patients. Additional research is needed to determine proper 
age-based dosing that is effective in treating malaria to prevent additional drug resistance. 
Conclusion 
 While malaria is both preventable and treatable, a significant number of people in Africa, 
particularly children below the age of 5-years old, are still dying from this disease on a daily 
basis. Progress that was made between 2000 and 2015 has stalled primarily due to financial 
constraints associated with insufficient funding, but other factors include inadequate education, 
drug resistance, insecticide resistance, and lack of adherence. While COVID-19 will likely 
further strain funding in coming years, it is imperative to implement interventions that are the 
most effective with minimal barriers to proper adherence, namely IRS. When implementing 
other programs such as ITN and LLIN distribution, emphasizing and including education can 
positively impact their efficacy and maximize protection for vulnerable populations.   
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